Hemispherian
Dr. Frans van Dalen is a Founding Partner of Meneldor. His experience spans more than 30 years in the (bio)pharmaceutical industry. He has held staff and senior managerial positions in Strategic Program Development, QA/QP, Project Management, R&D and Regulatory Affairs. Since 1992, he was one of the partners that built the Synthon group of companies (1,500 FTEs at 9 strategic locations globally) and was involved in the R&D, Regulatory Affairs, manufacturing and commercialization of generic medicines, biosimilars and new biological entities.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Hemispherian
Hemispherian is a biotechnology company developing new treatments for the most aggressive types of cancer. Its mission is to development a new drug to treat Glioblastoma Multiforme.